SAB Biotherapeutics (SABSW) Times Interest Earned (2021 - 2025)
SAB Biotherapeutics' Times Interest Earned history spans 5 years, with the latest figure at -$248.5 for Q4 2025.
- For Q4 2025, Times Interest Earned fell 75.97% year-over-year to -$248.5; the TTM value through Dec 2025 reached -$203.41, down 50.93%, while the annual FY2025 figure was -$203.41, 50.93% down from the prior year.
- Times Interest Earned reached -$248.5 in Q4 2025 per SABSW's latest filing, up from -$292.87 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $10.82 in Q1 2021 to a low of -$292.87 in Q3 2025.
- Average Times Interest Earned over 5 years is -$122.58, with a median of -$110.05 recorded in 2024.
- Peak YoY movement for Times Interest Earned: crashed 960.35% in 2022, then skyrocketed 41.73% in 2024.
- A 5-year view of Times Interest Earned shows it stood at -$110.81 in 2021, then increased by 19.12% to -$89.62 in 2022, then plummeted by 170.4% to -$242.35 in 2023, then surged by 41.73% to -$141.22 in 2024, then crashed by 75.97% to -$248.5 in 2025.
- Per Business Quant, the three most recent readings for SABSW's Times Interest Earned are -$248.5 (Q4 2025), -$292.87 (Q3 2025), and -$151.25 (Q2 2025).